Firdapse drives Catalyst Pharmaceuticals, Inc.’s revenue with a 37% CAGR since its 2019 launch, boosted by an FDA-approved 100 mg dose expansion ... However, Fycompa still faces generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback